Concurrent Radiosurgery and Systemic Therapies for Melanoma Brain Metastases: A Systematic Review.
Ontology highlight
ABSTRACT: Intracranial metastatic melanoma is a major challenge for neuro-oncological teams. Historically, treatment has focused on surgical or radiosurgical treatment of appropriate lesions, mostly for palliative purposes. Immunotherapies and other targeted therapies (BRAF/mitogen-activated protein kinase kinase inhibitors (BRAFi/MEKi)) are mainstays of advanced melanoma therapy, yet the optimal timing and synergistic properties of concurrent combinations of these systemic therapies and stereotactic radiosurgery (SRS) are poorly understood. We performed a systematic review of the MEDLINE and Scopus databases focused on outcomes after therapy using SRS and either immunotherapies or targeted therapies in an effort to define the optimal timing. We defined concurrent therapy as SRS within three months
SUBMITTER: Weaver BD
PROVIDER: S-EPMC6907724 | biostudies-literature | 2019 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA